Physician profile
Michael Mcclure
NPI 1093891400
$14,528.75
in general payments reported to CMS, 2019-2025
7 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2021: $13K · 2022: $143 · 2023: $494 · 2024: $164 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.20 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13,275.35 | 2019-2021 | |
| Abbvie INC. | $511.74 | 2023-2025 | |
| Galderma Laboratories, L.P. | $227.56 | 2019-2023 | |
| Integra Lifesciences Corporation | $173.44 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $132.13 | 2025 | Recell |
| Sientra, INC. | $123.53 | 2019 | |
| Medtronic, INC. | $85.00 | 2021-2023 | Merocel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.